Initial drug resistance pattern among pulmonary tuberculosis patients

Indian Journal of Tuberculosis

Volumn 60, Issue 3, 2013, Pages 154-161

  Gupta, Harshita ^a   Kant, Surya ^a   Jain, Amita ^a   Natu, S M ^a   Ahluwalia, Savita ^b  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b UNIVERSITY OF LUCKNOW   (India)

Author keywords

Initial drug resistance; Multi drug resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ACID FAST BACTERIUM; ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DRUG RESISTANT TUBERCULOSIS; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; SCHOOL CHILD; SHORT COURSE THERAPY; SPUTUM SMEAR; URBAN AREA;

ADOLESCENT; ADULT; ANTITUBERCULAR AGENTS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INCIDENCE; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 84883762597     PISSN: 00195707     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. World Health Organization, 2012. Available at: http://www.who.int/topics/tuberculosis/en/
2. Tiemersma EW, Marieke J. Vander Werf, Martien W. Borgdorff et al. Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIVnegative patients: A systematic review. PLoS ONE 2011; 6(4): 17601.
3. Global tuberculosis control: World Health Organization. WHO Report, 2011. Available at: www.who.int/tb/publications/global_report/2011.
4. Surya Kant, Anand K. Maurya, R. A. S. Kushwaha et al. Multi-drug resistant tuberculosis: An iatrogenic problem. Bio-science Trends 2010; 4(2): 48-55.
5. N. W. Schluger. Tuberculosis drug resistance in Europe: sunny days, but clouds on the horizon? European Respiratory Journal 2007; 30: 5825-7.
6. O'Grady Justin, Maeurer Markus, Mwaba Peter et al. New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis. Current Opinion in Pulmonary Medicine 2011; 17: 134-41.
7. A Faustini, A J Hall, and C A Perucci. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax 2006; 61(2): 158-63.
8. S. S. L Parashar. Social, Behavioural and Communication Sciences, 2012. Available at: http://www.whoindia.org/LinkFiles/Human_Resources_Section4Textbook_on_ Public_Health_and_Community_Medicine.pdf
9. Revised National Tuberculosis Control Programme. Training Module for Medical Practitioners, 2006. Available at: www.tbcindia.nic.in/pdfs/Financial%20Training%20 Module.pdf.
10. Revised National TB Control Programme Training Manual for Mycobacterium tuberculosis Culture & Drug susceptibility testing, 2009. Available at: http://www.tbcindia.nic.in/pdfs/Training%20manual%20M%20tuberculosis%20C%20DST.pdf
11. American Thoracic Society and Centers for Disease Control and Prevention. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161(4pt1): 1376-95.
12. Revised National Tuberculosis Control Programme. DOTSPlus Guidelines, 2010. Available at: www.health.bih.nic.in/Docs/Guidelines-DOTS-Plus.pdf.
13. Mycal Pereira, Srikanth Tripathy, Vikas Inamdar. Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian J Med Res 2005; 121: 235-9.
14. Paramasivan CN. An overview of drug resistant tuberculosis in India. Lung India 1998; 15: 21-8.
15. S.P. Rai, D. Bhattacharyya, M Kashyap. Pattern of Initial Drug Resistance and Its Impact on Short Course Chemotherapy of Pulmonary Tuberculosis. Lung India 2007; 24: 51-3.
16. Anti-tuberculosis drug resistance in the world. Fourth global report, 2002-2007. Available at: whqlibdoc. who. int/hq/2008/who_htm_tb_2008.394_eng. pdf
17. Sarala Menon, Sujata Dharmshale, Chhaya Chande et al. Drug resistance profiles of Mycobacterium tuberculosis isolates to first line anti-tuberculosis drugs: A five-year study. Lung India 2012; 29: 227-31.
18. Haji Khan Khoharo, Imran Ali Shaikh. Drug resistance patterns in pulmonary tuberculosis. JPMA 2011; 61: 229.
19. Dursun Tatar, Gunes Senol, Didem Cosar et al. Patterns of drug resistance in pulmonary tuberculosis cases in the Izmir district, Turkey. New Microbiologica 2009; 32: 31-7.
20. World Health Organization Report: Global Tuberculosis Control. Surveillance, planning and financing. Geneva, World Health Organization (WHO/HTM/TB/2005.349); 2005.
21. World Health Organization Report: Global Tuberculosis Control. Surveillance, planning and financing. Geneva, World Health Organization (WHO/HTM/TB/2006.362);2006.
22. World Health Organization Report: Global Tuberculosis Control. Surveillance, planning and financing. Geneva, World Health Organization (WHO/HTM/TB/2007.376); 2007.
23. B Mahadev, P Kumar, SP Agarwal et al. Surveillance of drug resistance to anti-tuberculosis drugs in districts of Hoogli in West Bengal and Mayurbhanj in Orissa. Indian J Tuberc 2005; 52(1): 5-10.
24. Sureshkumar D and Ram Gopalakrishnan. Drug Susceptibility Pattern of M. Tuberculosis Isolated from Patients Attending a Private Hospital. American Journal of Infectious Diseases 2011; 7(4): 104-6.
25. Soumya Swaminathan, C. Padmapriyadarsini, and G. Narendran. HIV-Associated Tuberculosis: Clinical Update. Clin Infect Dis 2010; 50(10): 1377-86.